• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌张力障碍的高剂量抗胆碱能疗法。

High-dosage anticholinergic therapy in dystonia.

作者信息

Fahn S

出版信息

Adv Neurol. 1983;37:177-88.

PMID:6134442
Abstract

Twenty-three children and 52 adults with torsion dystonia of various etiologies and distribution patterns of the involuntary movements were treated in an open-label study with anticholinergic medication. The dosage was build up gradually until there was either benefit or tolerable adverse effect. Trihexyphenidyl was used initially, but beginning in 1979, ethopropazine was utilized in the adult subjects. Significant benefit occurred in 61% of children and in 38% of adults.

摘要

在一项开放性研究中,对23名患有扭转性肌张力障碍(病因和不自主运动分布模式各异)的儿童以及52名成人使用抗胆碱能药物进行治疗。剂量逐渐增加,直至出现疗效或出现可耐受的不良反应。最初使用的是苯海索,但从1979年起,成人受试者改用乙丙嗪。61%的儿童和38%的成人有显著疗效。

相似文献

1
High-dosage anticholinergic therapy in dystonia.肌张力障碍的高剂量抗胆碱能疗法。
Adv Neurol. 1983;37:177-88.
2
High dosage anticholinergic therapy in dystonia.
Neurology. 1983 Oct;33(10):1255-61. doi: 10.1212/wnl.33.10.1255.
3
Dystonia: therapy with high dosage anticholinergic medication.肌张力障碍:高剂量抗胆碱能药物治疗
Indiana Med. 1987 Jun;80(6):552-3.
4
Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy.苯海索治疗脑瘫继发性肌张力障碍患儿的前瞻性开放标签临床试验。
J Child Neurol. 2007 May;22(5):530-7. doi: 10.1177/0883073807302601.
5
High dose anticholinergic therapy in adult dystonia.成人肌张力障碍的高剂量抗胆碱能治疗。
Can J Neurol Sci. 1986 Feb;13(1):42-6. doi: 10.1017/s0317167100035770.
6
Use of trihexyphenidyl in children with cerebral palsy.三己酚丁酯在脑瘫儿童中的应用。
Pediatr Neurol. 2011 Mar;44(3):202-6. doi: 10.1016/j.pediatrneurol.2010.09.008.
7
Double-blind evaluation of trihexyphenidyl in dystonia.苯海索治疗肌张力障碍的双盲评估
Adv Neurol. 1983;37:189-92.
8
Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs.
Mov Disord. 1988;3(1):46-60. doi: 10.1002/mds.870030107.
9
The predictive value of acute antimuscarinic drugs for the chronic efficacy of antimuscarinic drugs in adults with focal dystonia.急性抗毒蕈碱药物对成人局灶性肌张力障碍患者抗毒蕈碱药物慢性疗效的预测价值。
Adv Neurol. 1988;50:557-60.
10
Pharmacokinetics of trihexyphenidyl after short-term and long-term administration to dystonic patients.短期和长期给予张力障碍患者苯海索后的药代动力学。
Ann Neurol. 1985 Jul;18(1):35-40. doi: 10.1002/ana.410180107.

引用本文的文献

1
Direct cerebello-striatal loop in dystonia as a possible new target for deep brain stimulation: A revised view of subcortical pathways involved.肌张力障碍中直接的小脑-纹状体环路作为深部脑刺激可能的新靶点:对所涉及的皮质下通路的新认识。
Front Neurol. 2022 Aug 24;13:912818. doi: 10.3389/fneur.2022.912818. eCollection 2022.
2
The neurobiological basis for novel experimental therapeutics in dystonia.治疗肌张力障碍的新型实验治疗的神经生物学基础。
Neurobiol Dis. 2019 Oct;130:104526. doi: 10.1016/j.nbd.2019.104526. Epub 2019 Jul 4.
3
Emerging concepts in the physiological basis of dystonia.
扭转痉挛的生理基础中的新观念。
Mov Disord. 2013 Jun 15;28(7):958-67. doi: 10.1002/mds.25532.
4
Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia.DYT1 型肌张力障碍中纹状体内胆碱能中间神经元异常多巴胺 D2 受体反应的发育特征。
PLoS One. 2011;6(9):e24261. doi: 10.1371/journal.pone.0024261. Epub 2011 Sep 2.
5
Treating complex movement disorders in children with cerebral palsy.治疗脑瘫患儿的复杂运动障碍。
Ulster Med J. 2009 Sep;78(3):157-63.